Evidence map›Paper›PMID 38049342›Full record

ReviewZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2023

[Allogeneic hematopoietic stem cell transplantation combined with CD7 CAR-T for the treatment of T lymphoblastic lymphoma: a case report and literature review].

X M Wang, Y Zhou, J L Zhang, H Y Zhou, Q Zhang, Q Sun, H J Li, L Y Xu, S N Yao, Z H Yao and 3 more

Abstract readReviewCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Review in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

X M WangDepartment of Hematology, the Affiliated Hospital of Xuzhou Medical University, Blood Diseases Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou 221000, China.
Y ZhouDepartment of Hematology, the Affiliated Hospital of Xuzhou Medical University, Blood Diseases Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou 221000, China.
J L ZhangDepartment of Rehabilitation, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221000, China.
H Y ZhouDepartment of Hematology, the Affiliated Hospital of Xuzhou Medical University, Blood Diseases Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou 221000, China.
Q ZhangDepartment of Hematology, the Affiliated Hospital of Xuzhou Medical University, Blood Diseases Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou 221000, China.
Q SunDepartment of Hematology, the Affiliated Hospital of Xuzhou Medical University, Blood Diseases Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou 221000, China.
H J LiDepartment of Hematology, the Affiliated Hospital of Xuzhou Medical University, Blood Diseases Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou 221000, China.
L Y XuDepartment of Hematology, the Affiliated Hospital of Xuzhou Medical University, Blood Diseases Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou 221000, China.
S N YaoDepartment of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450000, China.
Z H YaoDepartment of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450000, China.
D M YanDepartment of Hematology, the Affiliated Hospital of Xuzhou Medical University, Blood Diseases Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou 221000, China.
K L XuDepartment of Hematology, the Affiliated Hospital of Xuzhou Medical University, Blood Diseases Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou 221000, China.
W SangDepartment of Hematology, the Affiliated Hospital of Xuzhou Medical University, Blood Diseases Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou 221000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hematopoietic Stem Cell TransplantationPrecursor T-Cell Lymphoblastic Leukemia-LymphomaReceptors, Chimeric AntigenAntigens, CD19HumansImmunotherapy, AdoptiveAntigens, CD19Receptors, Chimeric Antigen

Identifiers

PMID38049342
PMCPMC10694072

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.